FMW Media’s New to The Street TV announces the broadcastings of its
national syndicated shows
tonight, Monday, October 4,
2021 at 10:30 PM PT and
tomorrow,
Tuesday night, October 5,
2021 at 10:30 PM PT on Fox Business
Network.
New to The Street’s
242nd TV
show, airing tonight, Monday, October 4, 2021, 10:30 P.M. PT, on
the Fox Business Network,
features the following 5 Companies and their businesses
representatives:
1). Hapbee Technologies, Inc.’s (OTCQB:HAPBF)
(TSXV:HAPB) interview with Yona Shtern, CEO.
2). Tonix Pharmaceuticals, Inc.’s (NASDAQ:TNXP)
interview with Mr. Seth Lederman, CEO.
3). First Wave BioPharma, Inc.’s (NASDAQ:FWBI)
(formerly known as AzurRx BioPharma, Inc.) interview with James
Sapirstein, Chairman, CEO & President.
4). GlobeX Data, Ltd.’s (OTCQB:SWISF) (CSE:SWIS)
(FRA:GDT) interview with Mr. Alain Ghiai, CEO.
2). StrikeForce Technologies, Inc.’s
(OTCQB:SFOR) interviews with both Mr. Mark Kay, CEO and Mr. George
Waller Executive Vice-President.
Airing tonight, Monday,
October 4, 2021, Yona Shtern, Chief Executive Officer,
Hapbee Technologies, Inc. (OTCQB:HAPBF) (TSXV:HAPB) arrives
in-studio at NASDAQ, talking with New to The Street TV’s host Jane
King, about the Company’s Hapbee Smart Wearable wellness product.
Mr. Shtern gives the televised audience an overview on the
worldwide size of the wellness marketplace and explains the
wellness wearable products in this marketplace. The unique
difference in the Hapbee Smart Wearable in comparison to other
products is that the Hapbee Smart Wearable transmits a digital
signal into the human brain. He explains how the human bioreceptors
react to these digital signatures, which he describes as a “song.”
The Company’s wearable comes downloaded with 2 digital blends, but
the users can download other digital blends through a subscription
offered at the Company. The molecular signature of compounds like
caffeine, nicotine, CBD, and others relaxing sensations can provide
the Smart Wearable end-users benefits which don’t come with the
usual side-effects associated with oral consumptions. Jane King
gives her personal experience in using the product and looks
forward to giving more about her experience on future TV interviews
as she continues using Smart Wearable. With a comprehensive
marketing strategy, Yona, explains the business proposition and the
expected growth at Hapbee Technologies, Inc.
On tonight’s, Monday, October 4,
2021, New to The Street TV show, Tonix Pharmaceuticals,
Inc.’s (NASDAQ:TNXP) CEO, Seth Lederman, talks to TV with Host,
Jane King, in-studio at NASDAQ. The Company recently received FDA
guidance on its TNX-1800, Mr. Lederman explains the significance of
this guidance. Recently, the Company entered into a collaboration
with Columbia University in New York City, a scientific
relationship that focuses on the COVID-19 immune responses by both
people who recovered from COVID and those who were asymptomatic to
the virus. Seth explains the differences between a live virus
vaccine, which TNXP has in development, and the mRNA vaccines
currently being offered worldwide. He explains that the TNX -1800,
a live vaccine, has shown it disables the virus, limits forward
transmissions and can be a cheaper vaccine to deploy. Additionally,
Seth talks about the need for oral anti-viral pharmaceuticals for
the treatment of those infected with COVID-19, and he sees that the
combination of the TNXP’s oral product with Remdesivir have shown
strong clinical test results. Before conclusion of the interview,
Seth explains the unique relationship with himself, the Company and
Columbia University, and he remains excited on the scientific
outcomes on the recently announce collaborations and them working
together with the science of in vitro T-cells for the future of
vaccines.
Joining tonight, Monday, October 4,
2021, on the New to The Street’s TV show, the in-studio at
NASDAQ interview with Mr. James Sapirstein, Chief Executive Officer
at First Wave BioPharma, Inc. (NASDAQ:FWBI) (formerly known as
AzurRx Biopharma, Inc.), a clinical-stage biopharmaceutical Company
specializing in the development of targeted, non-systemic therapies
for gastrointestinal (GI) diseases. Mr. Sapirstein provides TV Host
Jane King a comprehensive update on corporate on-goings, and he
explains why they did a name change. He talks about new drug data
regarding ulcerative proctitis as it relates to colitis. The
Company has 4 active Phase II FDA trials, and he explains the
process and progress of each. James talks about niclosamide, and
the anticipate results in forthcoming trials as an oral medication
for the treatment of COVID-19. In conclusion, James explains that
being first-market with an oral COVID treatment could be a
game-changer for the world and for the Company.
Back again on tonight’s, Monday, October
4, 2021, New to The Street TV show, Mr. Alain Ghiai, CEO,
GlobeX Data, Ltd. (OTCQB:SWISF) (CSE:SWIS) (FRA:GDT) gives host Jan
King and viewers an update about the ever-growing corporate
fundamental at GlobeX Data, Ltd. and its Sekur® cybersecurity
products. Alain talks about the new Sekur email application and how
it works both protecting the sender and the receiver of email
transmissions. He describes the new advance technological equipment
recently purchased which gives the Company a technological
footprint to rollout email application. He gives a comparison on
what is cheaper, paying about $7.00 a month for a Sekur email
application or paying $30,000 to resolve identity theft and other
related “HACK” problems which can occur from an open-source email.
With most of the world using open-source emails, it is just a
matter of time before someone gets hacked. Recently, “phishing”
apps are now available on the dark web, whereas a person pays to
get a product to hack peoples’ emails, websites, and servers. Mr.
Ghiai states during the interview that we need to protect ourselves
from these hackers and the best possible way is to subscribe to
Sekur® email. Further, the billboard ad on GlobeX Data’s Sekur
product is now displayed on the NASDAQ building, the largest
billboard in Time-Square, New York City. Other electronic billboard
and media displays are posted throughout New York City, and Alain
explains this is an important piece of the Company’s sales and
marketing campaign as it grows it brand awareness throughout New
York City and eventually expands, as such, throughout the USA and
internationally. As Always, Mr. Ghiai explains and emphasizes how
GlobeX Data, Ltd. operates it internet platforms and security
businesses under the country of Switzerland’s very tough privacy
laws.
New to The Street TV, in-studio interviews at
NASDAQ, welcomes back on tonight’s show, Monday, October 4,
2021, StrikeForce Technologies, Inc.’s (OTCQB:SFOR) Mr.
Mark Kay, CEO, and Mr. George Waller, Executive Vice-President.
Both Company executives talk, in-studio at NASDAQ, to the New to
The Street TV host, Jane King, about SFOR’s cyber security products
and services that provides next-gen cyber, privacy and data
protection solutions for business and home users. Viewers hear Mr.
Waller who talks about the soon to close Reg A+ financing and
explains the use-of- proceeds to grow sales, develop more sales ads
and marketing strategies. With capital outlays focused on marketing
strategies, both Mr. Kay and Mr. Waller expect continued growth of
the Company’s GuardedID®, MobileTrust®, ProtectID® and SafeVchat
Meetings products and services. They both explain that their
Company’s unique cybersecurity products with enhanced protocols and
authentications eliminate “HACK” attacks on their clients,
especially while utilizing internet communications, chat, and video
on desktop computers. Mr. Waller introduced to the viewers the
Company’s new improved website, and Mr. Kay talks about the new
website for both product sales and the educational resource
available to provide answers and solutions to cybersecurity issues.
The SafeVchat product gives immediate controls to the online chat
organizer, controlling the chat which can eliminate unwanted
interruptions and uninvited participants, a common problem with
other competitive products online. With a pre-Covid market around
$2B, it now has grown exponentially for remote virtual meeting
products, and since Covid forced many to work remotely, both Mr.
Kay and Mr. Waller see a strong future for SFOR and its for their
shareholders.
==============================================================================================================================================================================
New to The Street’s 243rd
show, airing tomorrow night, Tuesday, October 5, 2021, 10:30 P.M.
PT, on the Fox Business Network,
features the following 5 Companies and their businesses
representatives:
1). Pharmagreen Biotech, Inc.’s (OTCPINK: PHBI)
interview with Mr. Peter Wojcik, CEO
2). Cryptocurrency Kylin Network’s
(CRYPTO:KYL)($KYL) interview with Mr. Dylan Dewdney, Chief
Stratosphere Officer (CSO).
3). Gaensel Energy Group,
Inc.’s (OTCPINK:GEGR) interview with Mr. Peter Koley, CFO.
4). Sekur’s® (division of GlobeX Data Ltd)
“SPECIAL SEGMENT” interview with internet privacy
expert with Mr. Alain Ghiai, CEO.
5). First Wave BioPharma, Inc.’s (NASDAQ:FWBI)
(formerly known as AzurRx BioPharma, Inc.) interview with James
Sapirstein, Chairman, CEO & President.
On Tuesday night’s, October 5,
2021, New to The Street TV airs the interview with Mr.
Peter Wojcik, Chief Executive Officer, Pharmagreen Biotech, Inc.
(OTCPINK:PHBI), who provides a comprehensive overview to TV Host,
Jane King. Throughout the interview, Peter talks about the pending
US SEC Reg A+ financing and explains the use-of-proceeds to grow
the Company’s starter cannabis plantlets through
its proprietary tissue culture process. With total proceeds of
cash and stock combination totaling approximately $2.4 Million,
PHBI should have adequate capital to complete the acquisition of
the California-based Cannabis Licensed Company and to construct
state-of-the-art greenhouse. Mr. Wojcik further explains that, upon
the closing of the acquisition, the Company intends to apply to the
State of California for a cannabis nursery license to enable it to
develop its “Tissue Culture Starter Plantlet” production facility.
He advises viewers who might be interested in participating in the
Reg A+ funding to read about it once available on the Company’s
website landing page at www.pharmagreen.ca. He thanks the viewers
and the Company’s shareholders and invited them to view future TV
interviews on the New to The Street’s syndicated airings and read
social media and website updates.
Once again, Mr. Dylan Dewdney, Chief Stratosphere
Officer (CSO) from Kylin Network (CRYPTO:KYL)($KYL), joins TV Host
Jane King on New to The Street TV in-studio at NASDAQ,
tomorrow night, Tuesday, October 5, 2021. Mr.
Dewdney explains the Kylin Network’s current DeFi data management
blockchain utilizing the $KYL token. “D-Data,” a term created at
Kylin which means decentralized data, is the unique focus on
corporate and individual data and how it can be monetarized for the
benefits of the owners of their data. Currently and too often, data
is sold to others with no compensation or to the knowledge of the
owners of that data. Kylin has the solutions, and Mr. Dewdney sees
a complete revolution on how data is handled, owned, shared, and
secured, at the same time paid-for-use. During the interview, Dylan
passionately sees where the regulatory issues need to be evaluated
both domestically and internationally.
New to The Street welcomes, on tomorrow
night, Tuesday, October 5, 2021 show, Gaensel Energy
Group, Inc.’s (OTCPink:GEGR) Chief Financial Officer, Mr. Peter
Koley. Talking with TV host Jane King, Mr. Koley gives the TV
viewers specific details about the Company’s comprehensive finance
modeling, as it pertains to growth companies positioned in the
global marketplace. With years of international business acumen,
Mr. Koley provides the focus of GEGR’s business in providing
capital investments for small to midsize entities. He offers
insight into the Company’s recent press release, about GEGR taking
a 40% shareholder stake in MonFerr SRL, and tells why this recent
transaction is a perfect example of how Gaensel operates its
business. Most small-to-medium-size businesses have cash-flow
problems, but they have sustainable and growing businesses. Mr.
Koley explains how Gaensel provides capital solutions which are
otherwise not obtainable through conventional legacy financial
options. The Board of Directors at Gaensel Energy Group each have
unique business acumens which complement the existing ang growing
business, and each provides their expertise in making decision on
capital transaction with the objective to be accretive to the
bottom-line at GEGR. Mr. Koley sees a bright and exciting future
for GEGR and its shareholders as they continue to grow their
business both in Italy and internationally.
Again, tomorrow night, Tuesday, October 5,
2021, New to The Street TV airs a “SPECIAL
SEGMENT” about Sekur® (division of GlobeX Data, Ltd.) with
the internationally acclaimed internet privacy expert, Mr. Alain
Ghiai, CEO. Talking with TV host Ann Berry, Alain enlightens the
viewers with his “HACK of the WEEK,” giving another real-world
problem in commonly used internet, texting, and video conferencing
platforms used by millions worldwide. This week, Alain talks about
the stolen Microsoft source codes as it pertains to the Solar Winds
Corporation hack. The so-called Microsoft “secret formula” is now
available to every nefarious dark web participant. He talks about a
recent shut-down of a pay-for-app on the dark web giving a person
the ability to go “phishing.” Using an open-source email platform
which is utilized by over 94% of the world, your so-called private
email transmissions are anything but private. Alain explains why
these open-source platforms are not safe. Even governmental
entities use these open-source platforms which are constantly under
“Hack Attacks.” He explains that the GlobeX Data, Ltd.’s Sekur
email, which protects both the sender and the receiver from privacy
breach, is a sure solution to the problem. He reminds viewers that
the Sekur platform never mines or sells your data, and the Company
generates its revenues from subscription fees from individuals and
corporations. Mr. Ghiai explains and emphasizes how GlobeX Data,
Ltd.’s SekurSuite® and Sekur® products work, and how their
subscribers benefit since the Company’s servers are located and
operate under the country of Switzerland’s very tough privacy
laws.
Once again for a second airing, tomorrow
night, Tuesday, October 5, 2021, the New
to The Street TV show welcomes the in-studio at NASDAQ interview
with Mr. James Sapirstein, Chief Executive Officer at First Wave
BioPharma, Inc. (NASDAQ:FWBI) (formerly known as AzurRx Biopharma,
Inc.), a clinical-stage biopharmaceutical Company specializing in
the development of targeted, non-systemic therapies for
gastrointestinal (GI) diseases. Mr. Sapirstein provides TV Host
Jane King a comprehensive update on corporate on-goings, and he
explains why they did a name change. He talks about new drug data
regarding ulcerative proctitis as it relates to colitis. The
Company has 4 active Phase II FDA trials, and he explains the
process and progress of each. James talks about niclosamide, and
the anticipate results in forthcoming trials as an oral medication
for the treatment of COVID-19. In conclusion, James explains that
being first-market with an oral COVID treatment could be a
game-changer for the world and for the Company.
About Hapbee Technologies, Inc.
(OTCQB:HAPBF) (TSXV:HAPB)
Hapbee Technologies, Inc. (OTCQB:HAPBF)
(TSXV:HAPB) is a wearable magnetic field technology Company that
aims to help people enhance how they feel. Powered by patented
ultra-low radio frequency energy (ulRFE®) technology, Hapbee
delivers low-power electromagnetic signals designed to produce
sensations such as Happy, Alert, Focus, Relax, and others,
available for purchase at www.Hapbee.com.
About Tonix Pharmaceuticals Holding Corp.
(NASDAQ: TNXP):
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP)
is a clinical-stage biopharmaceutical company focused on
discovering, licensing, acquiring and developing small molecules
and biologics to treat and prevent human disease and alleviate
suffering. Tonix's portfolio is primarily composed of the central
nervous system (CNS) and immunology product candidates. The CNS
portfolio includes both small molecules and biologics to treat
pain, neurologic, psychiatric and addiction conditions. Tonix's
lead CNS candidate, TNX-102 SL1, is in mid-Phase 3 developments for
the management of fibromyalgia, and positive data on the RELIEF
Phase 3 trial were recently reported. The Company expects interim
data from a second Phase 3 study, RALLY, in the third quarter of
20212 and top-line data in the fourth quarter of 2021. The
immunology portfolio includes vaccines to prevent infectious
diseases and biologics to address immunosuppression, cancer, and
autoimmune diseases. Tonix's lead vaccine candidate, TNX-18003, is
a live replicating vaccine based on the horsepox viral vector
platform to protect against COVID-19, primarily by eliciting a T
cell response. Tonix reported positive efficacy data from animal
studies of TNX-1800 in the first quarter of 2021. TNX-8013, live
horsepox virus vaccine for percutaneous administration, is in
development to protect against smallpox and monkeypox –
www.tonixpharma.com; 1TNX-102 SL is an investigational new drug and
has not been approved for any indication.2Pending agreement from
FDA on statistical analysis plan.
About First Wave BioPharma, Inc.
(NASDAQ:FWBI): First Wave BioPharma, Inc. (NASDAQ:FWBI) is
a clinical-stage biopharmaceutical company specializing in the
development of targeted, non-systemic therapies for
gastrointestinal (GI) diseases. First Wave is currently advancing a
therapeutic development pipeline populated with multiple clinical
stage programs built around its two proprietary technologies –
niclosamide, an oral small molecule with anti-viral and
anti-inflammatory properties, and the biologic adrulipase, a
recombinant lipase enzyme designed to enable the digestion of fats
and other nutrients. First Wave’s niclosamide portfolio is led by
three clinical programs: FW-COV, for COVID-19 gastrointestinal
infections; FW-UP, for ulcerative proctitis (UP) and ulcerative
proctosigmoiditis (UPS); and FW-ICI-AC, for Grade 1 and Grade 2
Immune Checkpoint Inhibitor-associated colitis (ICI-AC) and
diarrhea in advanced oncology patients. Two additional formulations
of niclosamide, FW-UC (for ulcerative colitis) and FW-CD (for
Crohn’s disease) are expected to enter the clinic in 2022 and 2023,
respectively. First Wave is also advancing FW-EPI (adrulipase) for
the treatment of exocrine pancreatic insufficiency (EPI) in
patients with cystic fibrosis and chronic pancreatitis. The Company
is headquartered in Boca Raton, Florida with clinical operations in
Hayward, California - www.firstwavebio.com.
About GlobeX Data, Ltd. (OTCQB:SWISF)
(CSE:SWIS) (FRA:GDT):
GlobeX Data, Ltd. (OTCQB:SWISF) (CSE:SWIS)
(FRA:GDT) is a Cybersecurity and Internet Privacy provider of Swiss
hosted solutions for secure communications and secure data
management. The Company distributes a suite of secure messaging
applications, encrypted e-mails, secure communications, and secure
data management tools, using Swiss privacy laws, proprietary
technology, and its own independent platform, away from big techs
hosting platforms. GlobeX Data, Ltd. sells its products through its
approved wholesalers and distributors, and telecommunications
companies worldwide. GlobeX Data, Ltd. serves consumers, businesses
and governments worldwide – https://www.globexdata.com. Sekur® is a
Swiss secure communications application offering secure and private
messaging, emails, voice messages, self-deleting messages, and file
transfers from any mobile device, tablet, or desktop. Sekur users
can communicate with Sekur and with non-Sekur users, through its
unique Chat-By-Invites feature and Sekur, send email system. All
data traffic stays in GlobeX Data’s Swiss hosted servers, using its
proprietary HeliX technology, military grade encryption and
benefiting from Swiss Privacy Laws – https://sekur.com. Twitter:
@globexdata.
About StrikeForce Technologies, Inc.
(OTCQB:SFOR):
StrikeForce Technologies, Inc. (OTCQB:SFOR)
provides a suite of online products that helps prevent cyber theft
and data breaches by protecting customers, employees and partners
in real time at every vulnerable point. Our Products are:
ProtectID®: offers 2-factor "Out-of-Band" authentication across
many methods and devices for protection. Methods that is preferable
and low cost for delivering One Time Passwords (OTP). This approach
leverages a 2nd network for entering or receiving passwords, which
locks out hackers even if they have your username and password.
Service is available for in-house, Cloud Service or hybrid. (Patent
Nos.: 7870599 & 8,484,698 & 8,713,701). GuardedID®: a
keyboard encryption and anti-keylogger that functions at the
keyboard level, preventing keyloggers (viruses like Zeus, etc.)
from stealing login and confidential information. This has become
the #1 Consumer Threat noted by the FBI and the 2010-2013 Verizon
Data Breach Reports. Three Patents for keystroke encryption, US
Patents 8,566,608; 8,732,483; and 8,973,107 and two pending
patents. MobileTrust® is an iPhone/iPad and Android all devices
password vault that includes a strong password generator.
MobileTrust also includes a Mobile Multi-Factor OTP authenticator
and keystroke encryption between its virtual keyboard and secured
browser, which is critical to all confidential online transactions
and other features (One International Patent Pending). Our new
product secure SafeVchat is a video conferencing product -
https://www.strikeforcetech.com/.
About Kylin Networks
(CRYPTO:KYL)($KYL):
Kylin Networks (CRYPTO:KYL)($KYL) aims to build a
cross-chain platform, powering the data economy on Polkadot by
offering any applications and blockchain instantaneously but
reliable and valid on/off-chain market date and social data. Kylin
Network represents extensibility and a synergistic increase to the
off-chain worker's capability as it will provide not only access,
management, insights, coordination to a greater array of data
sources, but bolster validity and decentralization of the data
sources themselves. Using the Polkadot/Substrate framework, Kylin
Network can ensure cost-effective solution that data customers and
Dapp Builders can use over centralized sources. The architecture at
Kylin Network includes 4-major components, Kylin Data Analytics,
Kylin Data Oracle, Kylin Data Marketplace, and Kylin Token KYL
($KYL) - https://kylin.network/ &
https://www.kylin.network/video/kylin.mp4.
About Gaensel Energy Group, Inc.
(OTCPINK:GEGR):
Gaensel Energy Group, Inc. (OTCPINK:GEGR) is an
international finance and holding company which combines the
cumulative and collective knowledge of its management team. Its
management team consists of experienced professionals in Europe,
Asia, North and Latin America with proven success. GEGR has
expanded rapidly through a series of fifteen highly diversified
acquisitions or investments. The Company currently consists of a
wide variety of industries including Biotech, Commodities, Apparel,
Fashion, Green and Renewable Energy, and Technology. The Company's
revenues and earnings have grown considerably because of these
acquisitions. GEGR has the accounting, legal and management
organization with structural skill sets to effectively evaluate and
make prompt business decisions and the resource network to
facilitate high level transactions - https://gegrgroup.com/.
About Pharmagreen Biotech, Inc.
(OTCPINK:PHBI):
Pharmagreen Biotech, Inc. (OTCPINK:
PHBI) is a publicly traded company. Pharmagreen Biotech Inc.
is in the business of providing the highest quality starter
cannabis plantlets through its proprietary tissue culture
process, "Chibafreen", to licensed growers and to CBD hemp farmers
with its proprietary hemp strain "CBD Dana" for high CBD hemp
farming. It also provides other value-added services: plant species
identification through DNA testing and certification; live storage
of strains using tissue culture low temperature storage proprietary
technology. Utilizing the best tissue cultured plantlets in its
state of art greenhouse(s) for highest quality flower tops and
biomass production - www.pharmagreen.ca.
About FMW Media: FMW Media
operates one of the longest-running U.S. and International
sponsored and Syndicated Nielsen Rated programming T.V. brands "New
to the Street," and its blockchain show "Exploring The Block."
Since 2009, these brands run biographical interview segment shows
across major U.S. Television networks. The TV platforms reach over
540 million homes both in the US and international markets. FMW
recently added Newsmax to its broadcasting platform with its first
show broadcasted Sunday, December 27th. The NEWSMAX New to The
Street show is syndicated on Sundays at 10 AM EST. FMW is also one
of the nation's largest buyers of linear Television long and short
form - https://www.newsmaxtv.com/Shows/New-to-the-Street &
https://www.newtothestreet.com/
Forward-Looking Statements
Disclaimer:
This press release contains forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended. In some cases, you can identify
forward-looking statements by the following words: "anticipate,"
"believe," "continue," "could," "estimate," "expect," "intend,"
"may," "ongoing," "plan," "potential," "predict," "project,"
"should," "will," "would," or the negative of these terms or other
comparable terminology, although not all forward-looking statements
contain these words. Forward-looking statements are not a guarantee
of future performance or results and will not necessarily be
accurate indications of the times at, or by, which such performance
or results achieved. This press release should be considered in
light of all filings of the Company contained in the Edgar Archives
of the Securities and Exchange Commission at www.sec.gov.
FMW Media Contact: Bryan Johnson +1 (631) 766-7462
Bryan@NewToTheStreet.com
And
“New to The Street” Business Development
officeSupport@NewtoTheStreet.com 1-516-696-5900
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/e848d64d-bc5e-4951-a32c-96455094ad12
Tonix Pharmaceuticals (NASDAQ:TNXP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tonix Pharmaceuticals (NASDAQ:TNXP)
Historical Stock Chart
From Apr 2023 to Apr 2024